Cargando…

Effects of recombinant human brain natriuretic peptide in patients with acute myocardial infarction undergoing percutaneous coronary intervention: A systematic review and meta-analysis

OBJECTIVE: To systematically review the effect of recombinant human brain natriuretic peptide (rhBNP) on the cardiac function in patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI). METHODS: PubMed, Web of Science, the Cochrane Library, Chinese Biomedi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ning, Cheng, Zheng, Yawei, Li, Jie, Liu, Ming, Fang, Zhuyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	3400
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220387/ https://www.ncbi.nlm.nih.gov/pubmed/32176080 http://dx.doi.org/10.1097/MD.0000000000019479

Ejemplares similares

Association between RDW and stent thrombosis in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
por: Tunçez, Abdullah, et al.
Publicado: (2017)

Rapid Early Triage by Leukocytosis and the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: An Observational Study
por: Yeh, Yen-Ting, et al.
Publicado: (2016)

A case report of acute myocardial infarction with extremely severe thrombocytopenia after percutaneous coronary intervention
por: Chen, Shuai, et al.
Publicado: (2023)

Efficacy of Adenosine in Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A PRISMA-Compliant Meta-Analysis
por: Gao, Qijun, et al.
Publicado: (2015)

Effect of Beta Blockers and Renin–Angiotensin System Inhibitors on Survival in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Lee, Pil Hyung, et al.
Publicado: (2016)

The triglyceride-glucose index and contrast-induced nephropathy in non-ST elevation myocardial infarction patients undergoing percutaneous coronary intervention
por: Gursoy, Erol, et al.
Publicado: (2023)

Periprocedural myocardial and renal injury in patients undergoing elective percutaneous coronary interventions – is there an association?
por: Stipinovic, Mario, et al.
Publicado: (2019)

Brain natriuretic peptide as a biomarker for predicting contrast-induced nephropathy in patients undergoing coronary angiography/intervention: A systematic review and meta-analysis
por: Wu, Xuefeng, et al.
Publicado: (2022)

Percutaneous coronary intervention for congenital absence of the right coronary artery with acute myocardial infarction: A case report and literature review
por: Liu, Wei-Chao, et al.
Publicado: (2020)

Outcomes of off- and on-hours admission in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: A retrospective observational cohort study
por: Geng, Jin, et al.
Publicado: (2016)

The efficacy and safety of Shenfu injection in patients undergoing percutaneous coronary intervention for ST segment elevation myocardial infarction: A protocol for systematic review and meta-analysis
por: Yan, Xiafeng, et al.
Publicado: (2023)

Cardiac rehabilitation in acute myocardial infarction patients after percutaneous coronary intervention: A community-based study
por: Zhang, Yong, et al.
Publicado: (2018)

Influences of different dose of tirofiban for acute ST elevation myocardial infarction patients underwent percutaneous coronary intervention
por: Wang, Haixia, et al.
Publicado: (2020)

Prediction of no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
por: Yang, Li, et al.
Publicado: (2020)

Impact of Chronic Total Occlusion in a Noninfarct-related Artery on Clinical Outcomes in Patients With Acute ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Zhang, Hui-Ping, et al.
Publicado: (2016)

Serum Apelin Level Predicts the Major Adverse Cardiac Events in Patients With ST Elevation Myocardial Infarction Receiving Percutaneous Coronary Intervention
por: Liu, Hai-Tao, et al.
Publicado: (2015)

Survival rate after acute myocardial infarction in patients treated with percutaneous coronary intervention within the left main coronary artery according to time of admission
por: Januszek, Rafał, et al.
Publicado: (2021)

High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in East Asian patients undergoing percutaneous coronary intervention: A meta-analysis of fifteen randomized controlled trials
por: Liu, Jiahui, et al.
Publicado: (2021)

CHA(2)DS(2)-VASc score predicts the slow flow/no-reflow phenomenon in ST-segment elevation myocardial infarction patients with multivessel disease undergoing primary percutaneous coronary intervention
por: Huang, Xin, et al.
Publicado: (2021)

Cardiac mortality benefit of direct admission to percutaneous coronary intervention–capable hospital in acute myocardial infarction: Community registry–based study
por: Kang, Min Gyu, et al.
Publicado: (2021)

Impact of administration of nicorandil prior to percutaneous coronary intervention in treatment of acute myocardial infarction: A protocol for systematic review and meta-analysis
por: Li, Weijun, et al.
Publicado: (2021)

The number of stents was an independent risk of stent restenosis in patients undergoing percutaneous coronary intervention
por: Tang, Long, et al.
Publicado: (2019)

The renoprotective effects of simvastatin and atorvastatin in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational study
por: Ma, Huan, et al.
Publicado: (2017)

A novel de-escalation antiplatelet therapy for patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Li, Yachao, et al.
Publicado: (2023)

Elevated preoperative HMGB1 as predictor of myocardial injury post-percutaneous coronary intervention
por: Jin, Peng, et al.
Publicado: (2016)

Effect of drug-eluting stents on 1-year risk of new-onset atrial fibrillation in patients with acute myocardial infarction treated with percutaneous coronary intervention
por: Yu, Fa-Chang, et al.
Publicado: (2020)

Long-term outcomes of delayed percutaneous coronary intervention for patients with ST-segment elevation myocardial infarction: A propensity score-matched retrospective study
por: Xue, Yu-Long, et al.
Publicado: (2021)

Phase I cardiac rehabilitation with 5-phase music after emergency percutaneous coronary intervention for acute myocardial infarction: A prospective randomized study
por: Yao, Xu, et al.
Publicado: (2023)

Carbohydrate antigen 125 combined with N-terminal pro-B-type natriuretic peptide in the prediction of acute heart failure following ST-elevation myocardial infarction
por: Xu, Kaizu, et al.
Publicado: (2022)

Association of pre-percutaneous coronary flow grade and clinical outcomes in patients with non-ST-segment elevation myocardial infarction: Data from the Korea Acute Myocardial Infarction Registry
por: Kim, Yong Hoon, et al.
Publicado: (2021)

Efficacy of postprocedural anticoagulation after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A post-hoc analysis of the randomized INNOVATION trial
por: Song, Pil Sang, et al.
Publicado: (2019)

Prognostic implication of systemic inflammatory state on antiplatelet effect in patients after percutaneous coronary intervention for ST-elevation myocardial infarction: A retrospective cohort study
por: Jiang, Hairui, et al.
Publicado: (2021)

Percutaneous mechanical circulatory support devices in high-risk patients undergoing percutaneous coronary intervention: A meta-analysis of randomized trials
por: Shi, Wenhai, et al.
Publicado: (2019)

Myocardial protective effect of intracoronary administration of nicorandil and alprostadil via targeted perfusion microcatheter in patients undergoing elective percutaneous coronary intervention: A randomized controlled trial
por: Zhang, Weifeng, et al.
Publicado: (2021)

Predictive performance of aortic arch calcification for clinical outcomes in patients with acute coronary syndrome that undergo percutaneous coronary intervention: A prospective clinical study
por: Ma, Xiaoteng, et al.
Publicado: (2019)

Effect of recombinant human brain natriuretic peptide (rhBNP) versus nitroglycerin in patients with heart failure: A systematic review and meta-analysis
por: Zhang, Sijie, et al.
Publicado: (2016)

A study of the sequential treatment of acute heart failure with sacubitril/valsartan by recombinant human brain natriuretic peptide: A randomized controlled trial
por: Pang, Zhihua, et al.
Publicado: (2021)

Effects of recombinant human brain natriuretic peptide combined with tolvaptan on cardiac and renal function and serum inflammatory factors in patients with severe heart failure
por: Yang, Jing, et al.
Publicado: (2023)

Effect of trimetazidine on incidence of major adverse cardiac events in coronary artery disease patients undergoing percutaneous coronary intervention: A protocol for systematic review and meta-analysis
por: Zhu, Kun, et al.
Publicado: (2020)

Prediction of gastrointestinal bleeding events in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational cohort study (STROBE compliant)
por: Zheng, Wen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_36nl70lt5tg30ocdpa9fp3djvh